The GREACE study emphasizes the urgent need for a wider use of lipid-lowering drugs in high-risk patients. Evaluation (GREACE) Study consisted of patients with coronary heart disease (CHD) followed up for three years1. The patients were randomised to either. Our post-hoc analysis of the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) study was done to address this issue. Because of the.

Author: Taushura Nerr
Country: Mauritius
Language: English (Spanish)
Genre: Automotive
Published (Last): 4 September 2015
Pages: 373
PDF File Size: 20.30 Mb
ePub File Size: 16.51 Mb
ISBN: 920-4-17116-660-7
Downloads: 35920
Price: Free* [*Free Regsitration Required]
Uploader: Vule

You are a close professional associate of any of the authors e. You may not use the website for any unlawful purpose, including without limitation, to upload, post, download or grrace use any Material that you do not have the copyright owners permission to so upload, post, download or otherwise use, or that would result in you being in breach of these terms and conditions.

I am an author of this article. Register Already registered with FPrime? The use of certain tools provided by this website is subject to additional Terms and Conditions. By posting Material grace grant to F an irrevocable non-exclusive royalty-free license to keep a copy of Material for a reasonable period and as necessary to enable it to comply with its legal obligations.

Comment in Curr Med Res Opin. stuyd

You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. Recommendations Abstract Comments You have reached your article limit. Examples of ‘Financial Competing Interests’ You expect to receive, or in the past 4 years have received, any of the following from any commercial organization that may gain studdy from your submission: You are an Editor for the journal in which the article is published.

This Agreement shall begin on the date hereof. Disclosures Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality.

Statin treatment is sutdy and can improve liver tests and reduce cardiovascular morbidity in patients with mild-to-moderately abnormal liver tests that are potentially attributable to non-alcoholic fatty liver disease. Any view or opinion expressed in any Material is the view or opinion of the person who posts such view or opinion.


Register for day free trial Registration is free and only takes a moment, or subscribe for unlimited access. I am a Faculty Member who recommended this article. Withdrawal of patients because of side-effects from the atorvastatin group was low 0. All sttudy were followed up for a mean period of 3 years.

To assess the greacr of atorvastatin on morbidity and mortality total and coronary of patients with established coronary heart disease CHDgreacs patients were randomised either to atorvastatin or to ‘usual’ medical care. Examples of ‘Non-Financial Competing Interests’ Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. F does not store recipient email addresses. Erratum in Curr Med Res Opin.

Accordingly you may only post Material that you have the right to do so. You are entitled to post or upload the Material on the website and have all necessary licenses and consents to do so; the Material does not infringe any intellectual property right, including without limitation copyright, patent or trademark, or other proprietary right of any third party; the Material does not contain any defamatory, libellous, offensive, indecent or otherwise unlawful material or material which is an invasion of privacy; the Material does not contain any contaminating or destructive features or devices such as viruses, time bombs or coding designed to interrupt, destroy or limit the functionality of this website or any of this website’s user’s computer equipment or software; the Material will not be used to solicit or promote business or custom or present commercial activities or unlawful activity; and the Material is in compliance with all applicable laws.

This entry form currently does not support special characters.

Consider the following examples, but note that this is not an exhaustive list:. Secondary endpoints were the safety and efficacy of the hypolipidaemic drugs as well as the cost-effectiveness of atorvastatin.

A summary of the content will be automatically included.


The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study – UCL Discovery

Don’t have an account? Institutional access Recommend FPrime to your librarian or information manager to request an extended sthdy trial for all users at your institution.

However, there is no long-term survival study that evaluated this statin. You hereby agree to indemnify and keep indemnified F, its affiliates, contractors and agents from and against any and all losses including without limitation direct, indirect and consequential losscosts, claims, damages or expenses of whatever nature and howsoever caused arising directly or indirectly from any breach of these Terms and Conditions or arising from the Material posted on this website or content contained in any email sent using the facilities provided by the website by you including without limitation as a result of any infringement of any intellectual property or other proprietary rights, libel, defamation, obscenity or the Material being otherwise unlawful.

Please disclose any competing interests that might be construed to influence your judgment of the validity or importance of the article, or any recommendation or review.

The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.

These terms shall be governed by and construed in accordance with English Law. Recommend to your librarian. F reserves the right to monitor all Material and to remove any Material gresce it considers in its absolute discretion to be unlawful, inappropriate, offensive or otherwise in breach of these Terms and Conditions. Atorvastatin is very effective in reducing plasma low-density lipoprotein cholesterol LDL-C levels.

Certain parts of this website offer the opportunity for users to post opinions, information and material including without limitation academic papers and data ‘Material’ in areas of the website. You work at the same institute as any of the authors. Neither of the above. Consider the following examples, but note that this is not an exhaustive list: